Zimmer Biomet Holdings Stock In The News

ZBH Stock  USD 120.02  1.28  1.06%   
The overall news coverage of Zimmer Biomet Holdings from major news outlets shows solid bullish sentiment on 13 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of Zimmer Biomet's news coverage and content from conventional and social sources shows investors' bearish mood towards Zimmer Biomet Holdings. The specific impact of Zimmer Biomet news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Zimmer Biomet's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Zimmer Biomet headlines in addition to utilizing other, more conventional financial analysis modules. Check out Zimmer Biomet Backtesting and Zimmer Biomet Hype Analysis.

Zimmer Biomet Today Top News and Investor Outlook

Yahoo News
Has Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Stock's Recent Performance Got Anything to Do With Its Financial Health?
https://finance.yahoo.com/news/zimmer-biomet-holdings-inc-nyse-112637277.html
 Bullish
sbwire news
7 Robotic Surgery Stocks to Buy for the Future of Healthcare
https://investorplace.com/2024/03/7-robotic-surgery-stocks-to-buy-for-the-future-of-healthcare/
 Bullish
Yahoo News
Cardinal Health (CAH) Hits 52-Week High: What's Driving It?
https://finance.yahoo.com/news/cardinal-health-cah-hits-52-135600294.html
 Bullish
Yahoo News
Zimmer Biomet (ZBH) Rides on ROSA Uptake, Favorable Trend
https://finance.yahoo.com/news/zimmer-biomet-zbh-rides-rosa-122500246.html
 Bullish
Yahoo News
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
https://finance.yahoo.com/news/heres-why-zimmer-biomet-zbh-144012325.html
 Bullish
Yahoo News
Universal Health (UHS) Q4 Earnings Beat on Adjusted Admissions
https://finance.yahoo.com/news/universal-health-uhs-q4-earnings-141300254.html
 Bullish
Yahoo News
Does Zimmer Biomet Holdings (NYSE:ZBH) Deserve A Spot On Your Watchlist?
https://finance.yahoo.com/news/does-zimmer-biomet-holdings-nyse-141421163.html
 Bullish
Yahoo News
Select Medical (SEM) Q4 Earnings Beat on Patient Admissions
https://finance.yahoo.com/news/select-medical-sem-q4-earnings-172200378.html
 Bullish
Yahoo News
Zimmer Biomet Receives FDA Clearance for ROSA® Shoulder System - the World's First Robotic Assistant for Shoulder Replacement Surgery
https://finance.yahoo.com/news/zimmer-biomet-receives-fda-clearance-123000315.html
 Bullish
Yahoo News
Here's Why You Should Buy Zimmer Biomet (ZBH) Stock Now
https://finance.yahoo.com/news/heres-why-buy-zimmer-biomet-121700462.html
 Bullish

Zimmer Biomet Holdings Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Zimmer and other traded companies coverage. We help investors stay connected with Zimmer headlines for the 18th of April 2024 to make an informed investment decision based on correlating the impacts of news items on Zimmer Stock performance. Please note that trading solely based on the Zimmer Biomet Holdings hype is not for everyone as timely availability and quick action are needed to avoid losses.
Zimmer Biomet's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Zimmer Biomet Holdings investors visualize upcoming and past events in order to time the market based on Zimmer Biomet Holdings noise-free hype analysis.
Zimmer Biomet stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Zimmer earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Zimmer Biomet that are available to investors today. That information is available publicly through Zimmer media outlets and privately through word of mouth or via Zimmer internal channels. However, regardless of the origin, that massive amount of Zimmer data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Zimmer Biomet news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Zimmer Biomet relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Zimmer Biomet's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Zimmer Biomet alpha.

Zimmer Largest EPS Surprises

Earnings surprises can significantly impact Zimmer Biomet's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2002-10-21
2002-09-300.30.330.0310 
2002-04-24
2002-03-310.250.280.0312 
2002-07-24
2002-06-300.30.340.0413 
2005-01-31
2004-12-310.640.710.0710 
2005-04-25
2005-03-310.670.750.0811 
2008-01-29
2007-12-311.041.180.1413 
View All Earnings Estimates

Zimmer Biomet Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Zimmer Biomet Holdings Stock. Current markets are slightly bullish. About 56% of major world exchanges and indexes are currently up. See today's market update for more information.
Simply Wall St News at Macroaxis
17th of April 2024
Zimmer Biomet Holdings NYSEZBH investor three-year losses grow to 26 percent as the stock ...
at simplywall.st 
Yahoo News
11th of April 2024
SmithNephew Expands in Australia With New Alliance
at finance.yahoo.com 
Yahoo News
10th of April 2024
Why Zimmer Biomet is a Top Value Stock for the Long-Term
at finance.yahoo.com 
benzinga news
4th of April 2024
Zimmer Biomet Becomes First and Only Official Medical Device Partner of Association of Pic...
at benzinga.com 
Simply Wall St News at Macroaxis
2nd of April 2024
Zimmer Biomet Holdings, Inc.s Has Had A Decent Run On The Stock market Are Fundamentals In...
at simplywall.st 
news
1st of April 2024
3M completes Solventum healthcare business spinoff
at massdevice.com 
Yahoo News
25th of March 2024
Global Electrosurgery Market Report 2024 Market to Reach 8.99 Billion by 2031 - In-Depth A...
at finance.yahoo.com 
Yahoo News
22nd of March 2024
China Dental Market Analysis, Size and Forecasts Report 2024 A 115 Billion Industry by 203...
at finance.yahoo.com 
Yahoo News
1st of March 2024
Disposition of 2052 shares by Sang Yi of Zimmer Biomet subject to Rule 16b-3
at finance.yahoo.com 
seekingalpha News
22nd of February 2024
Zimmer Biomet wins FDA clearance for ROSA Shoulder System
at seekingalpha.com 

Zimmer Biomet Investors Sentiment

The influence of Zimmer Biomet's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Zimmer. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Zimmer Biomet's public news can be used to forecast risks associated with an investment in Zimmer. The trend in average sentiment can be used to explain how an investor holding Zimmer can time the market purely based on public headlines and social activities around Zimmer Biomet Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Zimmer Biomet's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Zimmer Biomet's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Zimmer Biomet's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Zimmer Biomet.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Zimmer Biomet in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Zimmer Biomet's short interest history, or implied volatility extrapolated from Zimmer Biomet options trading.
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:
Check out Zimmer Biomet Backtesting and Zimmer Biomet Hype Analysis.
Note that the Zimmer Biomet Holdings information on this page should be used as a complementary analysis to other Zimmer Biomet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Zimmer Stock analysis

When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Is Zimmer Biomet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.16)
Dividend Share
0.96
Earnings Share
4.88
Revenue Per Share
35.43
Quarterly Revenue Growth
0.063
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.